PharVision Advisers’s Hudbay HBM Stock Holding History

PharVision Advisers’s Portfolio HBM Stock Details HBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,069	Closed	-$228K	–	818
2025 Q3	$228K	Buy	+15,069	New	+$173K	0.13%	400

Other funds holding HBM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's HBM Position: Q4 2025 in Review

PharVision Advisers sold out of Hudbay (HBM) in Q4 2025, closing a stake of 15,069 shares — an estimated $228K sold.

PharVision Advisers first reported a position in HBM in Q3 2025 and held it in 1 quarter. The position peaked at $228K in Q3 2025. 273 funds tracked by Wall St. Rank hold HBM as of Q4 2025.

PharVision Advisers reported no remaining Hudbay position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 15,069 Hudbay shares in Q4 2025, an estimated $228K.
PharVision Advisers first reported a position in Hudbay in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Hudbay position peaked at $228K in Q3 2025.
273 funds tracked by Wall St. Rank held Hudbay as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.